When is a scientific study not a scientific study? That was a question posed by several panelists during a two-hour session on medication Jan. 25 during the National HBPA winter convention.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
- By Tom LaMarra
An official with the RMTC said confidentiality agreements used when the organization considers research to set thresholds and withdrawal times for medications are necessary because of scientific factors.
Regulatory administration of race-day anti-bleeding medication in Kentucky has provided a clearer picture of drug testing and produced added security benefits, officials said.
The Racing Medication and Testing Consortium board of directors has approved thresholds and withdrawal guidelines for six medications that have been identified as having therapeutic purposes.
The Racing Medication and Testing Consortium has hired Dr. Dionne Benson as executive director and chief operating officer.
Most Popular Stories
- California Chrome Returning Early From Break
- Arizona's Global Symposium Registration Open
- 95% Clearance Rate on Day 2 at Tattersalls
- 'Power' Pair Square Off in July Cup
- Boston and Suffolk Downs Begin Planning
- 'Princess' Looks Tough in Delaware Handicap
- Paladin Bay Seeks to Tame Bison City Stakes
- Isabella Sings First Winner for Eskendereya
- Social Inclusion Breezes for Haskell
- Xpressbet to Sponsor West Virginia Derby